Chemical Properties:
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Commercial Supply Dapoxetine Hydrochloride and Related Intermediates: 3-Chloropropiophenone CAS: 936-59-4 (S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4 (S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8 (R)-Diphenylprolinol CAS: 22348-32-9 (S)-Diphenylprolinol CAS: 112068-01-6 (S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1 Dapoxetine Hydrochloride CAS: 129938-20-1| Item | Specifications |
| Appearance | White to Off-White Crystalline/Colorless to Pale Yellow Oily Liquid |
| Purity | ≥98.0% |
| Loss on Drying | ≤0.50% |
| Specific Rotation [α]D20 | -22.0°~ -26.0° (C=1 in CHCl3) |
| Test Standard | Enterprise Standard |
| Usage | Dapoxetine Hydrochloride Pharmaceutical Intermediate |
Description:
Specifications:
Package & Storage:
| Chemical Name | (S)-3-Amino-3-Phenylpropan-1-ol |
| Synonyms | (S)-3-Amino-3-Phenyl-1-propanol; (S)-1-Phenyl-3-Propanolamine |
| CAS Number | 82769-76-4 |
| CAT Number | RF-PI153 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C9H13NO |
| Molecular Weight | 151.21 |
| Melting Point | 68.0~69.0℃ |
| Boiling Point | 273.23°C at 760 mmHg |
| Density | 1.0406 g/cm3 |
| Shipping Condition | Shipped Under Ambient Temperature |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-3-Amino-3-Phenylpropan-1-ol (CAS: 82769-76-4) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis. (S)-3-Amino-3-Phenylpropan-1-ol (CAS: 82769-76-4) can be used in the synthesis of Dapoxetine Hydrochloride (CAS: 129938-20-1). Dapoxetine Hydrochloride is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder, estimated to affect up to 30% of men.
